Quick Takeaways
- Laurence W. Lytton filed SCHEDULE 13G/A for AYTU BIOPHARMA, INC Common Stock (AYTU).
- Disclosed ownership: 10%.
- Date of event: 30 Sep 2025.
Laurence W. Lytton - 30 Sep 2025 SCHEDULE 13G/A Report for AYTU BIOPHARMA, INC Common Stock (AYTU)
- Filing Manager
- Laurence W. Lytton
- Reporting Manager
- LYTTON LAURENCE W
- Security
- AYTU BIOPHARMA, INC Common Stock
- Symbol
- AYTU
- Shares outstanding
- 10,876,096 shares
- Disclosed Ownership
- 1,086,522 shares
- Ownership
- 10%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Nov 2025, 13:26:30 UTC
- Date of event
- 30 Sep 2025
- Previous filing
- 13 Jun 2025
- Next filing
- 17 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Laurence W. Lytton disclosed 10% ownership in AYTU BIOPHARMA, INC Common Stock (AYTU) on 30 Sep 2025."
What Changed
- Previous schedule filing date: 13 Jun 2025.
- Current filing was accepted on 14 Nov 2025, 13:26.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| LYTTON LAURENCE W | 10% | 1,086,522 | 1,054,752 | 31,800 | /s/ Laurence W. Lytton | Reporting Person | |
| Lytton-Kambara Foundation | 10% | 1,086,522 | 1,054,752 | 31,800 | /s/ Laurence W. Lytton | President |